Exchange: OTC·Updated 02:57 PM EDT

GBLX GB Sciences Inc

$0.0004
$0.0001
(33.33%)
Today
Mkt Cap$162,828.00
Vol1,600.00

About GBLX

GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.
47

Neutral Sentiment

How do you feel about GBLX?

Advertisement|Remove ads.